lansbergen
Senior Member (Voting Rights)
Lost or reduced sense of smell and loss of taste for me are sighns it multiplies in nose and mouth.
Thank you Jonathan.Even when a lot is known I think there will be no absolute answer - it will be a matter of gradually reducing statistical risk. But I think you probably have a pretty good analysis already. Seven days from symptom onset seems risky, if only because the virus can survive on surfaces for a few days. I would be thinking more in terms of 7 days after being completely well or even more like 14. More than 14 seems unlikely to be necessary. Of course as things are at present the ideal advice would be not to change the make up of a household until we are over the current period of trying to reduce infection rates. The mild illness might not be Covid19 but she might pick it up the day she travels. On the other hand tricky decisions will need taking sometimes just to keep people sane.
Dr Tardif of the Institute of Cardiology of Montreal announced today that his group will be treating 6000 people suffering from Covid-19 with an anti-inflammatory called, "Koshesyn." That is not the correct spelling but I cannot find this med online so I have written it phonetically. He says that they hope to dampen and shorten the symptoms, so that patients do not risk going into full blown pneumonia.
A virus that jumps species can indeed cause symptoms. The issue is the target molecule it uses to enter the cell. Viruses for other species will typically not bind to a human version. If it mutates enough to do so then it might indeed cause symptoms, because the critical issue is can it bind to its target receptor and enter the cell. Symptoms might not be identical across species though.Yes that seems a bizarre statement surely that would make it a virus that wouldn't cause symptoms in us?
I do not know this drug and its not coming up on a Google search for me. It might be a misspelling. Antiinflammatories might indeed help, but could also increase lethality. This is because many will suppress the immune system, depending on their specific mode of action. If it acts on cyclooxygenase or a cortisol pathway it might be a problemDr Tardif of the Institute of Cardiology of Montreal announced today that his group will be treating 6000 people suffering from Covid-19 with an anti-inflammatory called, "Koshesyn."
Yes, Alex, it's Colchicine, as Dr Edwards pointed out. I kept hearing the word on the Radio Canada station and did not have spelling. Also, this morning I listened to English CBC and the chap was interviewing some researchers (USA and Cdn) and they said they are confident that 'in a couple of months' there will be the possibility to use repurposed drugs to address the severity and symptoms of Covid-19.I do not know this drug and its not coming up on a Google search for me. It might be a misspelling. Antiinflammatories might indeed help, but could also increase lethality. This is because many will suppress the immune system, depending on their specific mode of action. If it acts on cyclooxygenase or a cortisol pathway it might be a problem
Thanks, I started to suspect that after I wrote the post, as there was another thread on Colchicine, though I cannot find it now, maybe it merged.Yes, Alex, it's Colchicine, as Dr Edwards pointed out.
Referring to the loss of smell and taste in people who get sick, I haven't seen any mention of whether it comes back when the patient recovers. Does anyone know if it does?
Not to disagree, but to clarify for some readers, we have vaccines now. What we do not know is safety and efficacy, hence the commencement of trials. Once a vaccine is found effective and acceptably safe, we then need to expedite approval, manufacture in quantity, then distribute to where its needed and set up vaccination programs in local areas. Its a long road, hence the delays.
It does no good to suddenly release a vaccine that does not work, or even worse, is substantially dangerous in its own right. If testing is rushed it could add to the chaos, not help it.
https://www.ad.nl/binnenland/oproep-bloedbank-genezen-coronapatient-kom-plasma-geven~aef2de50/
Bloodbanks in NL are gathering plasma from cured patients to help fix the disease in other patients. I can't translate at the moment, too tired. But with google translate people should be getting a long way.
The blood does need to be tested. This is an article about a recent Stanford investigation into other viruses that may be present. They are sharing it early at the request of the California Department of Public Health.@Jonathan Edwards - is this likely to be a safe treatment, in the sense of the plasma (or antibodies or whatever, if anything, they're extracting from it) not carrying other infections?
https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333
Of the 49 positive SARS-COV-2 results, 11 (22.4%) also had a co-infection. Of the 127 positive for other viruses, 11 (8.66%) had a SARS-COV-2 co-infection. These co-infection rate are much higher than previously reported rates.
The blood does need to be tested. This is an article about a recent Stanford investigation into other viruses that may be present. They are sharing it early at the request of the California Department of Public Health.
Code:https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333